Zdrowie i gospodarka · 24/11/1995
FDA Extends Comment Period for Prescription Drug Labeling Rule
The Food and Drug Administration (FDA) has extended the comment period for its proposed rule on Prescription Drug Product Labeling; Medication Guide Requirements until December 22, 1995, in response to several requests from stakeholders.
Source: Federal Register — Food and Drug AdministrationOpen original release →